New SER-155 Phase 1b study biomarker data in allogeneic hematopoietic stem cell transplantation (allo-HSCT) recipients demonstrate that SER-155 ...

An FDA-approved medication called glucarpidase could serve as an antidote to kidney toxicity in patients receiving the chemotherapy drug methotrexate (MTX), according to a new study by investigators ...

Physiomics said its software was initially developed to help clinicians with chemotherapy dosing decisions, but the results of a Partner study in January 2023 indicated that the software could be ...

However, Mr Jervis only received a course of antibiotics some 20 hours after it was noted that he needed the medication. Mr ...

The addition of Monjuvi to standard-of-care therapy reduced the risk of disease progression, relapse, or death in patients ...

Incredible” results from the PATINA trial suggested a new standard of care for HER2, ER-positive metastatic breast cancer.

Mersana Therapeutics (MRSN) announced positive initial clinical data from the Phase 1 dose escalation and backfill cohorts for emiltatug ...

These supportive-care drugs are used to reduce the risk of a life-threatening complication called febrile neutropenia in cancer patients undergoing chemotherapy. HICOR is an institute at Fred Hutch ...

China NMPA approves Astellas Pharma’s Padcev in combination with Keytruda to treat advanced bladder cancer: Tokyo Thursday, January 9, 2025, 09:00 Hrs [IST] Astellas Pharma Inc.

Mathematical modelling, data science and biostatistics specialist Physiomics announced on Wednesday that its Innovate ...

Objective: To systematically evaluate the literature to determine whether vancomycin-induced neutropenia is dose- or duration-related and provide clinicians with feasible treatment alternatives.